wHY zEbOX™
ZeBox™ from Biomoneta® is a cutting-edge air decontamination technology that works in the presence of humans to trap & kill microbes which cause disease and product contamination. Our technology has been validated for 99.999% efficiency in 20 minutes by an ICMR/NABL/ISO-accredited laboratory, one of the few facilities in India to use airborne-pathogen testing, not just surface-based testing.
Our continuous-use, no-touch devices are built around this disruptive technology that finds application in multiple environments requiring clean, germ-free air.
We are infection biology and engineering specialists, supported by the Department of Biotechnology, Govt. of India and the Govt. of Karnataka. We have won multiple awards from leading multinational companies.
The ultimate validation of our devices is from our users, some of whom are themselves biology experts who have an exactingly high standard of no room for germs in human presence, not met by any other product in the market.
Our continuous-use, no-touch devices are built around this disruptive technology that finds application in multiple environments requiring clean, germ-free air.
We are infection biology and engineering specialists, supported by the Department of Biotechnology, Govt. of India and the Govt. of Karnataka. We have won multiple awards from leading multinational companies.
The ultimate validation of our devices is from our users, some of whom are themselves biology experts who have an exactingly high standard of no room for germs in human presence, not met by any other product in the market.
The problem at Hand
- A simple truth is being revalidated every day now: "When pathogens change, antibiotics and vaccines can stop working". While Covid-19 is the current focus in the world, older airborne infectious diseases such as pneumonia, tuberculosis, mucormycosis continue to claim lives . New research shows that drug resistant fungi is now in nature and not restricted to hospitals.
- While no one solution fits all, the surest way to infection control is to eliminate pathogens.
- Microbe-free clean environments are also vital to prevent business losses in the manufacturing and logistics of medical devices, biotechnology products and pharmaceuticals.
- Contaminating microbes can adversely impact outcomes in research laboratories.
ZeBox™ FEATURES
|
Broad spectrum
Traps & kills virus, fungi, bacteria, and spores that cause Healthcare acquired infections and spores causing the sick building syndrome. Human presence
Operates continuously and safely, achieving high efficiency in the presence of humans. |
Extreme efficiency
Up to 99.9% efficiency in the real world >99.999% eliminated in 20 mins in test conditions. No toxic by-products
The device does not change the air with radiation, free radicals nor any other toxic by-products. |
Ease of use
Plug-and-play device with unique airflow design that prevents clogging and allows easy maintenance of the device. No equipment damage
Designed for intensive care environments, there is no impact on any equipment in the same room as the device. |
Safety
IEC certified for electrical safety. EMI/EMC emissions are within acceptable thresholds. Zero maintenance
ZeBox™ is autonomous with only component replacements as needed. Turn it on and forget about it. |
How it works
ZeBox™ decontaminates the environment with its patent-pending technology that not only captures but also kills microbes before they can infect people or contaminate products.
|
1. ZeBox™ sucks in air from the environment where it is deployed and takes it into its capture zone.
|
2. The microbes move into the trap zone and are retained there.
|
3. The device's highly-efficient lysing mechanism disintegrates the cells, killing microbes in large numbers.
|
|
4. The cellular debris is trapped on the lysing surface as aggregates.
|
5. When the device is on, this cycle continues, maintaining a microbe-free environment.
|
6. Turning off the device leaves a clear field for the microbes to build up again.
|
It is what it is because you allowed it to be so.
suzy kassem
Team
Dr. Janani VenkatramanChief Executive Officer
Dr. Janani Venkatraman is the CEO at Biomoneta, where she leads strategy and management. Janani has 20+ years of experience in various fields of biology, with over ten years focused on infection drug discovery. Janani was part of the founding team of Bugworks, a cutting-edge drug discovery company innovating treatments for antibiotic resistant infections. Previously, she was a team leader at AstraZeneca India, where she helped manage the early discovery portfolio and provided scientific leadership.
Janani received a Ph.D. in Molecular Biophysics from the Indian Institute of Science and trained as a FRAXA fellow at Yale University, USA. Janani has multiple publications in international journals to her credit. |
Arindam GhatakChief Technology Officer
Arindam is the CTO at Biomoneta, where he leads technology development and Research. He has over 8 years’ experience working across multiple domains ranging from infectious disease to systems and synthetic biology. He has been deeply involved with multiple technology iterations and grants at Biomoneta since 2014. He has previously worked with Cellworks Research, where he developed an algorithm to decipher the mode of action of a novel antibacterial compound using graph theory.
Arindam graduated from the University of Calcutta with a degree in Biophysics and Molecular Biology. |
K.S. RamanujanHead - Engineering
Ram is the Head of Engineering at Biomoneta. Ram has been working with cutting-edge technologies for over 30 years (VLSI, embedded systems and systems biology mathematical modelling). He has also been the Honorary Professor, BITS Pilani, handling IC fabrication technology, VLSI synthesis, DFT and VLSI testing and Analog IC. Previously, he was involved with Cellworks, where he led the Systems Biology computational platform, used to design drugs for Cancer, Inflammation, and Infection. Ram is also specialized in Intellectual Property and served as Director, IP at Lakshmikumaran & Sridharan.
Ram graduated with a Siemens Gold medal as an electrical engineer from IIT, Madras. |
Ecosystem
Supported by
Awards and Grants
- Selected in 2020 for Applied Materials grant for COVID-19
- Recipient in 2020 of Covid-19 Consortium grant from BIRAC - Department of Biotechnology, Government of India
- Selected in 2019 at C-CAMP's National Bio Entrepreneurship Competition for the Pfizer Entrepreneurship Award
- Selected in 2019 by IIGP2.0 as one of India’s top 50 technology startups
- Selected in 2019 by PwC/FICCI as one of India’s top 30 startups across sectors
- Recipient in 2018 of Small Business Innovation Research Initiative (SBIRI) grant from BIRAC - Department of Biotechnology, Government of India
- Recipient in 2017 of Ideas2PoC grant from KBITS, Department of IT & BT, Government of Karnataka
- Recipient in 2017 of Small Business Innovation Research Initiative (SBIRI) grant from BIRAC - Department of Biotechnology, Government of India
Testimonials
"The decontamination device was placed in Pandorum's R&D scale manufacturing unit where an implantable medical device was under pre-clinical development and creating a sterile workplace was a mandate. Biomoneta deployed their novel air-decontamination technology to create the sterile environment required. The overall microbial load reduced by approximately 100 times. This fulfilled our requirement."
Dr.Muthu Dhandapani, Senior Manager - Facility, QA & RA
Pandorum Technologies, Bengaluru
Pandorum Technologies, Bengaluru
"Tissue culture facility of our lab at inStem is a busy place with bookings throughout the day. It houses both the insect cell and the mammalian cell cultures used by people from NCBS, CCAMP and inStem. The room has been remodeled as the BSL2 facility and we have been initially worried about the quality of the air and keeping the cultures contamination free. After having the ZeBox™ from Biomoneta placed in the facility the bacterial load has been reduced almost by 10 fold and we have not faced any contamination issues so far and the protein expression is at its prime."
Dr. Lahari Yeramala, Post Doctoral Fellow
TIFR-NCBS, Bengaluru
TIFR-NCBS, Bengaluru
"My mother underwent an advanced surgery in February, that led to a lot of post-surgical complications with burns all over her body and she needed to be in a very sterile environment. Upon bringing her home, the one thing that has kept her company since February, has been ZeBox. This device sitting inside her room, is what I think, has kept her infection-free and also extends its aid to my family as well. We are very, very thankful to Biomoneta, go ZeBox!"
Dr. Anand Anandkumar
CEO, Bugworks, Bengaluru
Member, India Advisory Board, Global Antibiotic R&D Partnership
CEO, Bugworks, Bengaluru
Member, India Advisory Board, Global Antibiotic R&D Partnership